Article Figures & Data
Figures
- Figure 1.
Flow cytometric analysis of PO in human OPM-2 myeloma cells. 1×105 cells were cultured with or without 0.1 μM PO for three days. Cell viability was measured by DIOC6 staining in flow cytometry. A representative experiment is shown.
- Figure 2.
Flow cytometric analysis of PO in murine MPC11 myeloma cells. 1×105 cells were cultured with various concentrations of PO for three days. Then cell viability was measured by DIOC6 staining in flow cytometry. Results represent data from two separate experiments. Data are shown as means.
- Figure 3.
In vivo effect of PO in MPC11-bearing mice. PO was administered orally by gavage at a concentration of 450 μg/day/mouse. Tumor growth in mice is presented. Six animals were used in each group. The observation time was 60 days.
- Figure 4.
In vivo effect of PO in MPC11-bearing mice. PO was administered orally by gavage at a concentration of 450 μg/day/mouse. Overall survival of mice is presented. Six animals were used in each group. The observation time was 60 days.
Tables
In this issue
Jump to section
Related Articles
Cited By...
- In Vitro Apoptosis Induction by Fenofibrate in Lymphoma and Multiple Myeloma
- Griseofulvin Efficiently Induces Apoptosis in In Vitro Treatment of Lymphoma and Multiple Myeloma
- Targeting Prostate Cancer with a Combination of WNT Inhibitors and a Bi-functional Peptide
- Clofibrate Demonstrates Efficacy in In Vitro Treatment of Lymphoma and Multiple Myeloma
- In Vitro Efficacy of Naftifine Against Lymphoma and Multiple Myeloma
- Flunarizine Exhibits In Vitro Efficacy Against Lymphoma and Multiple Myeloma Cells
- In Vitro Efficacy of Cinnarizine Against Lymphoma and Multiple Myeloma
- Effect of Wnt Inhibitors in Pancreatic Cancer
- Targeting the Wnt/Beta-Catenin Pathway in Renal Cell Carcinoma
- Targeting Renal Cancer with a Combination of WNT Inhibitors and a Bi-Functional Peptide
- Targeting the Wnt/Beta-catenin Pathway with the Antifungal Agent Ciclopirox Olamine in a Murine Myeloma Model
- Increased In vivo Efficacy of Lenalidomide and Thalidomide by Addition of Ethacrynic Acid
- Influencing the Wnt Signaling Pathway in Multiple Myeloma